Skip to content

Pfizer PFE Deferred Taxes

Deferred Taxes at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$211M-23.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$7.01B+189%
Merck & Co. logo
Merck & Co.MRK
Amgen logo
AmgenAMGN
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
Moderna logo
ModernaMRNA

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+5.0%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$143.68B+11.1%
Enterprise value$206.35B+9.2%
P/E11.9×
P/S2.3×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's deferred taxes?
Pfizer (PFE) reported deferred taxes of $2.41B in Q1 2026.
How has Pfizer's deferred taxes changed year-over-year?
Pfizer's deferred taxes increased by 6.8% year-over-year, from $2.26B to $2.41B.
What is the long-term trend for Pfizer's deferred taxes?
Over 5 years (2020 to 2025), Pfizer's deferred taxes has grown at a -10.0% compound annual growth rate (CAGR), from $4.06B to $2.4B.